Speech-Language Pathologists in Cheltenham, PA Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Kimberly Kreider Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7629 Brookfield Rd, Cheltenham, PA 19012 Phone: 717-405-8766 |
Erin Wimmer Fadako, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 624 Boyer Rd, Cheltenham, PA 19012 Phone: 267-650-1930 |
Ms. Barbara Kotzin, M.A., M.ED. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 609 Central Avenue, Cheltenham, PA 19012 Phone: 215-663-0505 |
Danielle Krevitz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7955 Rolling Green Rd, Cheltenham, PA 19012 Phone: 215-806-7615 |
Ms. Ellen Auerbach Einhorn, MA, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1129 Coventry Rd, Cheltenham, PA 19012 Phone: 215-635-1823 |
News Archive
Modern wildfires pose new health risks for firefighters
As California's wildfire season gets underway in earnest this month — with crews working to contain a 14,000-acre blaze in rugged Modoc County on the Oregon border — new research underscores the risks that modern wildfires pose to firefighters' long-term health.
Clavis Pharma signs drug development and commercialisation agreement with Clovis Oncology
Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.
Chemical-based tooth whitening or bleaching agents may be harmful, ADA warns
The American Dental Association (ADA) today asked the U.S. Food and Drug Administration (FDA) to establish appropriate classifications for tooth-whitening chemicals.
Bristol-Myers Squibb divests its majority stake in Mead Johnson Nutritional
Bristol-Myers Squibb (New York, New York) is divesting its 83% majority stake in its last non-biopharmaceutical holding, Mead Johnson Nutritional (Evansville, Indiana).
IBS scientists create first nanoparticle-based tissue adhesive to seal bleeding and guide surgery
As open surgery has gradually been replaced by minimally-invasive and image-guided procedures, tissue adhesives are taking the place of sutures and surgical staples.
› Verified 2 days ago
Optometrists
Speech-Language Pathologists
Occupational Therapists
Chiropractors
Podiatrists
Physical Therapists